论文部分内容阅读
目的探讨气管支气管、肺血管成形术治疗肺癌的适应证、术中麻醉管理、气管支气管的切除范围、肿瘤侵及肺血管的处理及临床应用价值等问题。方法全组３１例，男２６例，女５例。年龄３４～６８岁，平均５６岁。单纯气管支气管、隆突、部分隆突切除成形术１５例，气管支气管、隆突并袖状肺血管、上腔静脉部分切除成形术４例；单纯肺血管成形术１２例。结果术后发生并发症５例，其中出血１例、肺不张２例、心力衰竭１例、切口及肺部感染１例。５例中死亡２例。随访３ｍｏ～５ａ３ｍｏ。５ｄ生存率３３．３％（５／１５）。结论气管支气管、肺血管成形术对扩大肺癌手术指征、缩小切除范围有重要价值。
Objective To explore the indications of tracheobronchial and pulmonary angioplasty in the treatment of lung cancer, the management of anesthesia during operation, the scope of tracheobronchial resection, the treatment of tumor invasion and pulmonary vasculature, and clinical application value. Methods The whole group consisted of 31 patients, 26 males and 5 females. Age 34-68 years old, average 56 years old. Only tracheobronchial, carina, part of the eminence resection angioplasty in 15 cases, tracheobronchial, carina and sleeve-like pulmonary vascular, partial vena cava resection plasty in 4 cases; simple pulmonary angioplasty in 12 cases. Results There were 5 postoperative complications, including 1 case of hemorrhage, 2 cases of atelectasis, 1 case of heart failure, 1 case of incision and pulmonary infection. Two patients died in 5 cases. Follow-up 3mo ~ 5a3mo. The 5-day survival rate was 33.3% (5/15). Conclusion Tracheobronchial and pulmonary angioplasty are of great value in expanding the surgical indications of lung cancer and reducing the extent of resection.